PR

Pradnya Raju Wakle

Active Director Director DIN 10623437
DIN 10623437 First appointment May 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value •••• Premium profile

About Pradnya Raju Wakle

Data last updated:

Pradnya Raju Wakle is a Director at Proteon Pharmaceuticals India Private Limited (since 2024). The company operates in Pharma. Proteon Pharmaceuticals India Private Limited reported revenue of ₹2.17 Cr (FY 2024).

DIN 10623437
Primary Designation Director
Industry Pharma
First Appointment 09 May 2024
Oldest Company Age 8 yrs
Largest company Proteon Pharmaceuticals India Private Limited · ₹2.17 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 May 20242017₹2.17 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Proteon Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Pradnya Raju Wakle

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pradnya Raju Wakle

Pradnya Raju Wakle currently holds 1 directorship: Proteon Pharmaceuticals India Private Limited (Director, since 09 May 2024, revenue ₹2.17 Cr (FY 2024)).

Pradnya Raju Wakle was first appointed on 09 May 2024 as Director at Proteon Pharmaceuticals India Private Limited.

The current boards of Pradnya Raju Wakle's companies include Arkadiusz Jozef Wojtasik (Proteon Pharmaceuticals India Private Limited), Marcio Caparroz Lopes Pinheiro (Proteon Pharmaceuticals India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available